Lopinavir-ritonavir does not improve the survival of patients with coronavirus.
For the treatment of coronavirus infection useless combination of the drugs lopinavir and ritonavir. This is evidenced by the results of a British clinical study RECOVERY published on June 29, reports the Chronicle.info with reference to the Correspondent.
According to researchers, a drug commonly used in HIV has no positive impact on patients with COVID-19.
In scientific work, they compared data 1 596 patients receiving a combination of these drugs, data 3 376 patients in the control group.
It is noted that due to the complexity of medication the study was conducted on patients connected to a ventilator.
The RECOVERY study is carried out since March this year, it involved 11.5 thousand patients.
For 100 days was obtained results which showed that two drugs − hydroxychloroquine and lopinavir-ritonavir do not improve the survival of patients with coronavirus, while dexamethasone “saves lives”.